SC issues notice to Centre on plea alleging shortage of anti-HIV drugs

The Supreme Court has sought response from the Centre and others on a plea alleging shortage of antiretroviral drugs for treating HIV patients in the country

Supreme Court, Benami Act
Press Trust of India New Delhi
1 min read Last Updated : Sep 20 2022 | 1:54 PM IST

The Supreme Court has sought response from the Centre and others on a plea alleging shortage of antiretroviral drugs for treating HIV patients in the country.

A bench of Justices D Y Chandrachud and Hima Kohli issued notice to the Ministry of Health, National AIDS Control Organisation and others on a plea filed by an NGO.

"The petitioners have submitted that there are shortages in the procurement of ART drugs in the country and the tender for 2021-22, which was due in August 2021, was issued in December 2021 and eventually failed. Issue notice, returnable in two weeks," the bench said.

Antiretroviral therapy (ART) is treatment of people infected with human immunodeficiency virus (HIV) using anti-HIV drugs.

The top court was hearing a plea filed by NGO Indian Network for People living with HIV/AIDS alleging shortage of antiretroviral drugs in the country.

The plea contended that non-availability of drugs at the Anti Retro Viral Therapy Centres of the National AIDS Control Organisation results in hampering ARV treatment of the people living with HIV/AIDS.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Supreme CourtCentreHIV/AIDS

First Published: Sep 20 2022 | 1:54 PM IST

Next Story